ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents
Protein kinases are one of the largest known families of enzyme characterized by having a well conserved ATP binding pocket. Most of the synthetic kinase inhibitors are ATP-competitive, but display some potential problems, like selectivity, discrepancy between the in vitro and in vivo inhibition assays and an high risk of developing mutation inside the ATP-binding pocket. Recently some new inhibitors with a non-competitive mechanism of action were reported, with intresting results both in vitro and in vivo.
Keywords: Ser/Thr kinase inhibitors, ATP non-competitive, anticancer drugs, drug discovery
Rights & PermissionsPrintExport